ACAD
27.64
-1.37
-4.72%
AEMD
2.15
0.00
N/A%
APRI
1.04
-0.05
-4.5780%
ARNA
15.23
0.00
N/A%
ATEC
1.79
0.00
0.00%
CNAT
5.46
0.00
N/A%
CRXM
0.175
0.00
N/A%
CYTX
1.176
+0.016
+1.3448%
DXCM
74.94
0.00
N/A%
GNMK
12.24
0.00
N/A%
HALO
13.99
0.00
N/A%
ILMN
176.36
-4.53
-2.50%
INNV
0.111
0.00
N/A%
INO
8.12
0.00
N/A%
ISCO
1.15
0.00
N/A%
ISIS
57.56
0.00
N/A%
LGND
119.21
+0.05
+0.04%
LPTN
2.93
0.00
N/A%
MBVX
1.44
0.00
N/A%
MEIP
2.31
-0.03
-1.28%
MNOV
5.26
0.00
N/A%
MRTX
3.75
0.00
N/A%
MSTX
0.131
0.00
N/A%
NBIX
45.56
0.00
N/A%
NUVA
77.125
+1.585
+2.098%
ONCS
1.18
0.00
N/A%
ONVO
2.66
0.00
N/A%
OREX
3.08
0.00
N/A%
OTIC
18.45
0.00
N/A%
QDEL
27.16
0.00
N/A%
RCPT
231.96
0.00
N/A%
RGLS
1.05
0.00
N/A%
RMD
77.02
0.00
N/A%
SCIE
0
0.00
N/A%
SPHS
2.41
0.00
N/A%
SRNE
2.05
0.00
0.00%
TROV
1.04
-0.03
-2.35%
VICL
2.54
0.00
N/A%
VOLC
18
0.00
N/A%
ZGNX
14.3
0.00
N/A%
ACAD
27.64
-1.37
-4.72%
AEMD
2.15
0.00
N/A%
APRI
1.04
-0.05
-4.5780%
ARNA
15.23
0.00
N/A%
ATEC
1.79
0.00
0.00%
CNAT
5.46
0.00
N/A%
CRXM
0.175
0.00
N/A%
CYTX
1.176
+0.016
+1.3448%
DXCM
74.94
0.00
N/A%
GNMK
12.24
0.00
N/A%
HALO
13.99
0.00
N/A%
ILMN
176.36
-4.53
-2.50%
INNV
0.111
0.00
N/A%
INO
8.12
0.00
N/A%
ISCO
1.15
0.00
N/A%
ISIS
57.56
0.00
N/A%
LGND
119.21
+0.05
+0.04%
LPTN
2.93
0.00
N/A%
MBVX
1.44
0.00
N/A%
MEIP
2.31
-0.03
-1.28%
MNOV
5.26
0.00
N/A%
MRTX
3.75
0.00
N/A%
MSTX
0.131
0.00
N/A%
NBIX
45.56
0.00
N/A%
NUVA
77.125
+1.585
+2.098%
ONCS
1.18
0.00
N/A%
ONVO
2.66
0.00
N/A%
OREX
3.08
0.00
N/A%
OTIC
18.45
0.00
N/A%
QDEL
27.16
0.00
N/A%
RCPT
231.96
0.00
N/A%
RGLS
1.05
0.00
N/A%
RMD
77.02
0.00
N/A%
SCIE
0
0.00
N/A%
SPHS
2.41
0.00
N/A%
SRNE
2.05
0.00
0.00%
TROV
1.04
-0.03
-2.35%
VICL
2.54
0.00
N/A%
VOLC
18
0.00
N/A%
ZGNX
14.3
0.00
N/A%

Headline »

December 23, 2016 – 1:35 pm

Join us for our famous life science speed networking event on January 30th, 2017! Bring lots of business cards, your elevator speech, and be ready to make new connections in 2017. Now more than ever, …

Read the full story »

Breaking San Diego Biotech News

New Study: DNA Tests For Healthy People Have “Uncertain Value”

June 28, 2017 – 2:30 am

Genome sequencing is becoming more common for people diagnosed with cancer. Should it become part of a healthy person’s checkup, too? A new study published Monday in the Annals of Internal…

[[Click headline to continue reading.]]

Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say.

June 26, 2017 – 4:50 am

By the end of this year, for the first time, patients with certain deadly types of blood cancer might have a new option, CAR-T cell therapy, to prolong their life. Immunotherapy could further…

[[Click headline to continue reading.]]

Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More

June 23, 2017 – 3:05 am

All eyes are on the nation’s capital this week, where the Senate released its version of the American Health Care Act (now called the Better Care Reconciliation Act) and the White House worked…

[[Click headline to continue reading.]]

Lilly Adds Chemistry Capabilities in San Diego Lab Expansion

June 22, 2017 – 2:41 pm

Eli Lilly (NYSE: LLY) has completed a $90 million expansion of its biotechnology R&D center in San Diego, added new automated synthesis equipment, and plans to build out its next-generation…

[[Click headline to continue reading.]]


See All News>>

Newest San Diego Biotech Jobs

Chief Technology Officer

Purpose of Job The CTO will be a member of the Company’s executive leadership team – guiding product strategy, technology development and the alignment of technology with Company’s business objectives to drive the development, launch, and competitive rele

Sr. Manager/Director, Accounting – Ajinomoto Althea, Inc. – San Diego, CA

Is a fully integrated contract development and manufacturing organization providing clinical drug process development and manufacturing services to global…From Ajinomoto Althea, Inc. – Wed, 28 Jun 2017 01:36:16 GMT – View all San Diego, CA jobs

Vice President, Clinical Development

Tocagen is a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within.
Every member of our t […

Vice President, Clinical Development

Tocagen is a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within.
Every member of our t […


See All Jobs>>